T1	Participants 624 678	previously untreated metastatic breast cancer patients
T2	Participants 1232 1335	Patients had to have histologically documented measurable breast cancer and a performance status of 0-1
T3	Participants 1337 1406	Patients could not have had prior chemotherapy for metastatic disease
T4	Participants 1451 1490	Patients could not have visceral crisis
